New case-control study investigating COVID-19 mRNA booster vaccination and miscarriage

Researchers from the HealthPartners Institute in Minneapolis, Minnesota (USA) have led the publication of a study using the Vaccine Safety Datalink (November 2021 to June 2022), comparing rates of third dose mRNA vaccine exposure in the 28 days prior to miscarriage or ongoing pregnancy. More information is available here.